Short answer
GoHealth, Inc. (GOCO) filed its Q3 2025 10-Q quarterly report on Nov 14, 2025 for the quarter ended Sep 30, 2025. Quarterly revenue was $34M (down 71.1% year over year) with net income of −$166M.
Q3 2025 key financials · XBRL
- Revenue
- $34M
- −71.1% YoY · −63.7% QoQ
- Net income
- −$166M
- −2547.9% YoY · −205.6% QoQ
- Operating margin
- -842.2%
- EPS (diluted)
- −$13.42
- −2264.5% YoY · −158.1% QoQ
Source: XBRL data from the GoHealth, Inc. (GOCO) Q3 2025 10-Q on SEC EDGAR. USD.
GoHealth, Inc. Q3 2025 10-Q analysis
AI summary of MD&A and risk factor updates
Risk Factors
- New risk: issuance of 4.77M Class A shares (16.66% post-closing) to lenders may pressure stock price upon resale or perception of resale
- Material update: strategic capital and governance actions on August 6, 2025, enable pursuing mergers, acquisitions, refinancing, increasing financial flexibility
- Legal risk: U.S. Attorney’s Office complaint filed May 1, 2025 intervening in qui tam action over sales and marketing practices, raising litigation and reputational risk
- Operational risk: 487-employee reduction in Q4 2025 as part of cash flow optimization may impact morale and ability to retain talent
- Financial risk: liquidity improved by August 6, 2025 Superpriority Credit Agreement; risk remains if covenants, including minimum liquidity, are breached causing default
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other GoHealth, Inc. quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.